The investment & research team at Rabbit Fund possesses a high level of professional expertise and extensive experience in research and investment.
- Mature and Stable Research Team
The founding team has been collaborating for over years, exhibiting strong synergy and organizational capabilities.
- Sector PM System
Within the decision-making and authorization scope of the Investment Committee, multiple industry portfolio managers work together to manage portfolios across various industries for the products under their supervision.
- Cultivating a High-Quality Professional Team
Rabbit Fund’s investment research team comprises nearly professionals from renowned domestic and international universities, including prestigious institutions like Tsinghua University, Peking University, and Oxford University. They have comprehensive industry coverage and a deep focus on fundamental analysis.
WU Weizhi
Founder Chairman Chief Investment Officer
Mr. Wu has over years of experience in the investment field, with the company managing over USD 3bn AUM. Rabbit Fund focuses its investments in China, Hong Kong and overseas secondary markets, through fundamental research to seek for companies of great growth. As a veteran in the market, he understands well the market cyclicality and has developed his own 'four seasons model', assisting the investment decisions. As one of the oldest privately-owned investment management firms in China, Rabbit Fund has been well recognized not only by its steady AUM, but also multiple awards received from the industry, including 1 Morningstar China Equity Hedge Fund Award, Golden Bull Awards, Jinhua Awards, Golden Sun Awards, 'Top 50 Best Private Managers in China' by Xincaifu, etc. All of which are affirmation to Mr. Wu’s value creation for his clients.
Guo Chaofeng
Co-General Manager, and Associate Investment Director
With a master's degree and years of experience in the financial industry, Guo Chaofeng possesses a deep understanding of overseas stock markets. He specializes in identifying investment opportunities in growth industries, particularly the technology sector, through a bottom-up approach. He effectively utilizes hedging tools to time the market and hedge against systemic risks while aiming for superior returns and controlling drawdowns.
Li Zhijun
Chief Risk Officer
With years of experience in the technology and financial industries, Li Zhijun brings extensive expertise in corporate finance, auditing, and risk management. She has a wealth of experience and a strong track record in effectively controlling financial risks within the industry. Li has successfully built the company's risk management system, streamlined risk control processes and protocols, and earned industry recognition for outstanding risk management and exceptional drawdown control capabilities.
Liu Fei
Senior Partner, and Associate Investment Director
With a master's degree and years of experience in securities investment research, Liu Fei oversees the overall research work of the investment team. By conducting in-depth analysis of industry cycles, upstream and downstream relationships, and competitive dynamics, he proactively identifies companies with competitive advantages within the industry chain, guiding the research team in uncovering promising investment targets. Liu employs a top-down approach to stock selection, demonstrating a deep understanding of cyclical investment logic. He focuses on allocating significant resources in areas of certainty.
Huang Songjie
Chief Strategy Officer and Associate Investment Director
With a master's degree and years of experience in securities investment research, Huang Songjie is responsible for using stock index futures to hedge systematic risks in the A-share market and making overseas derivative-related investments. He possesses a comprehensive understanding of the A-share market, excelling in position allocation and control from a cyclical perspective. Huang flexibly adjusts strategic directions through technical means.
Wang Yang
Director of the Research Department
With a master's degree and years of experience in securities investment research, Wang Yang is responsible for conducting investment research in overseas markets and the pharmaceutical industry. He possesses forward-thinking industry insights and excels at identifying investment opportunities from a top-down perspective. Wang adheres to value investing principles and seizes investment opportunities by discovering market blind spots.
WU Weizhi
Founder Chairman
Chief Investment Officer
Chief Investment Officer
Guo Chaofeng
Co-General Manager
Associate Investment Director
Associate Investment Director
Li Zhijun
Chief Risk Officer
Liu Fei
Senior Partner
Associate Investment Director
Associate Investment Director
Huang Songjie
Chief Strategy Officer
Associate Investment Director
Associate Investment Director
Wang Yang
Director of the Research Department